Abstract:Multiple biological barriers in solid tumors severely restrict the penetration of nanomedicines, which is a main cause for therapeutic failure in traditional tumor treatment. Here, a tumor-specific nanogenerator of peroxynitrite (ONOO–), prepared by loading cisplatin and sodium nitroprusside into poly(d,l-lactide-co-glycolide) polymersomes, was designed to improve drug delivery and enhance tumor chemotherapy. After a cascade of nicotinamide adenine dinucleotide phosphate oxidases catalysis and glutathione reduction, the nanogenerator, namely, PMCS, could selectively induce the generation of ONOO– in tumor. The generated ONOO– could not only strengthen vascular permeability significantly but also improve the accumulation and penetration of PMCS in tumor by activating matrix metalloproteinases-mediated degradation of extracellular matrix. Along with endocytosis, PMCS released cisplatin to induce tumor cell apoptosis. Moreover, free cisplatin liberated from dead cells infected neighboring tumor cells quickly via ONOO–-mediated up-regulated copper transporter 1, further amplifying chemotherapeutic efficacy. This study advances ONOO– as a potent modality to address the main issues of therapeutic delivery, including but not limited to chemotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c01312?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c01312</a>.Figures of TEM images, hydrodynamic size, DLS profiles, release of SNP, release of CDDP, hemolysis assay, superoxide anion generation, release of NO, representative CLSM images, flow cytometric analysis, mean fluorescence intensity, relative CDDP endocytosis, Trypan blue staining, intracellular ATP levels, blood circulation curve, DAX-J2 PON green staining, immunofluorescent staining, activity analysis, in vivo fluorescence imaging, mean fluorescence intensity values, tumor volume change, body weight change, H&E staining, and survival curves and tables of blood routine examination and blood biochemical analysis (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c01312/suppl_file/nn1c01312_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment

Tumor Microenvironment Targeting System for Glioma Treatment Via Fusion Cell Membrane Coating Nanotechnology.

Sphingosine 1‐Phosphate Liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against Brain Glioma Tumors

A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma

GSH‐Responsive Metal–Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy

On‐Demand Peroxynitrite Overproduction Reprograms Systemic Immune Function for Augmented Sono‐Immunotherapy against Tumor

Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma

Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy

Bionanoparticles with In Situ Nitric Oxide Release for Precise Modulation of ER‐TRPV1 Ion Channels in Multimodal Killing of Glioblastoma

Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma

Thermoresponsive Nanocomposite Gel for Local Drug Delivery to Suppress the Growth of Glioma by Inducing Autophagy

Black Phosphorus-Synergic Nitric Oxide Nanogasholder Spatiotemporally Regulates Tumor Microenvironments for Self-Amplifying Immunotherapy

Engineered Biomimetic Cancer Cell Membrane Nanosystems Trigger Gas-Immunometabolic Therapy for Spinal-Metastasized Tumors.

Catalytic nanoreactors promote GLUT1-mediated BBB permeation by generating nitric oxide for potentiating glioblastoma ferroptosis

Tumor-specific Nitric Oxide Generator to Amplify Peroxynitrite Based on Highly Penetrable Nanoparticles for Metastasis Inhibition and Enhanced Cancer Therapy

Synthetic High‐Density Lipoprotein‐Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity Against Glioma

Tumor-Specific ONOO – Nanogenerator for Improved Drug Delivery and Enhanced Chemotherapy of Tumor

Intelligent Nanoparticles With pH-Sensitive Co-Delivery of Temozolomide and siEGFR to Ameliorate Glioma Therapy

Enhanced glioma cell death with ZnO nanorod flowers and temozolomide combination therapy through autophagy and mitophagy pathways

Glutathione-Responsive Biodegradable Nanoplatform with Endogenous Esterase-Triggered Nitric Oxide Release for Gas Therapy and Enhanced Chemotherapy

Sustained Release of Nitric Oxide and Cascade Generation of Reactive Nitrogen/Oxygen Species via an Injectable Hydrogel for Tumor Synergistic Therapy